Section 523 of the FD&C Act has
authorized FDA to accredit third party organizations to conduct the
primary review of premarket notifications (510 K(s)) for certain
low and moderate risk devices. Persons required to submit a 510(k)
for these devices may contract with an accredited third party to
review the 510(K) and provide recommendation to FDA. Those who do
not wish to use a third party may submit the 510(K) directly to FDA
for review.
Daniel Gitteson 3017965156
daniel.gitteson@fda.hhs.gov
No
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.